Artem A. Artykov

Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL

Artem A. Artykov, Anne V. Yagolovich, Daria B. Trushina et al. · Frontiers in Cell and Developmental Biology · 2021 · 38 citations · Full text

Apoptosis, Cell Death, Cancer Biology +18

Chemotherapeutic Agents Sensitize Resistant Cancer Cells to the DR5-Specific Variant DR5-B More Efficiently Than to TRAIL by Modulating the Surface Expression of Death and Decoy Receptors

Artem A. Artykov, Dmitry Belov, Victoria O. Shipunova et al. · Cancers · 2020 · 20 citations · Full text

Chemoprevention Strategy, Immunology, Tumor Biology +16

A New Efficient Method for Production of Recombinant Antitumor Cytokine TRAIL and Its Receptor-Selective Variant DR5-B

Anne V. Yagolovich, Artem A. Artykov, Marine E. Gasparian · Biochemistry (Moscow) · 2019 · 18 citations

Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile

Anne V. Yagolovich, Artem A. Artykov, Alexander Andreev‐Andrievskiy et al. · Translational Oncology · 2020 · 16 citations · Full text

Chemoprevention Strategy, Opg Receptors, Colon Cancer Xenografts +19

Amphiphilic Poly(N-vinylpyrrolidone) Nanoparticles Conjugated with DR5-Specific Antitumor Cytokine DR5-B for Targeted Delivery to Cancer Cells

Anne V. Yagolovich, Andrey N. Kuskov, Pavel P. Kulikov et al. · Pharmaceutics · 2021 · 15 citations · Full text